SCHEMBL6301846

SCHEMBL6301846

[CH2]c1ccc(NC(=O)Nc2c(C)cccc2C)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.63
ALDH1A1 P00352 2/20 0.63
EPHB4 P54760 2/20 0.52
KDR P35968 1/20 0.52
TEK Q02763 1/20 0.52
MAPT P10636 5/20 0.51
RAB9A P51151 3/20 0.51
LMNA P02545 3/20 0.51
ALOX15 P16050 2/20 0.51
HTT P42858 1/20 0.51
HSD17B10 Q99714 1/20 0.51
POLB P06746 1/20 0.50
DRD2 P14416 1/20 0.49
HTR2A P28223 1/20 0.49
HTR2B P41595 1/20 0.49
IDH1 O75874 1/20 0.48
PTGS2 P35354 1/20 0.48
PKM P14618 1/20 0.47
MEN1 O00255 3/20 0.47
CYP1A2 P05177 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30051979 0.83 MAPT (0.67) KMT2AALDH1A1MAPTRAB9ALMNA
SCHEMBL17438146 0.83 LMNA (0.66) KMT2AALDH1A1MAPTRAB9ALMNA
SCHEMBL21230469 0.83 IDH1 (0.65) KMT2AALDH1A1MAPTRAB9AHTT
SCHEMBL687547 0.81 RAB9A (0.66) KMT2AALDH1A1KDRMAPTRAB9A
SCHEMBL6295212 0.79 NPSR1 (0.61) KMT2AALDH1A1MAPTRAB9ALMNA
SCHEMBL8020585 0.79 MDM2 (0.66) KMT2AALDH1A1MAPTRAB9ALMNA
SCHEMBL11011302 0.79 ALDH1A1 (0.58) KMT2AALDH1A1MAPTRAB9AHTT
SCHEMBL4954984 0.78 KMT2A (0.70) KMT2AALDH1A1MAPTRAB9ALMNA
SCHEMBL95460 0.77 SMN1; SMN2 (0.74) KMT2AMAPTRAB9ALMNAHTT
SCHEMBL2307872 0.77 S1PR4 (0.56) KMT2AALDH1A1MAPTLMNAALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6903128-B2 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases PFIZER INC (US) 2005-06-07 US disclosed
US-6667331-B2 For example 3-(2-(1-(2-(3-Methoxy-4-(3-o-tolyl-ureido)-phenyl)-acetylamino )-3-methyl-butyl)-4,5-dihydro-oxazol-5-yl)-2-methyl-propionic acid PFIZER INC 2003-12-23 US disclosed
US-6355662-B1 PEPTIDE AND NONPEPTIDES AUTOIMMUNE DISEASES, ANTIINFLAMMATORY AGENTS PFIZER INC 2002-03-12 US disclosed
US-6306887-B1 AROMATIC UREAS, CARBAMATES AND TRIAMINONITRILES AND HETEROCYCLIC COMPOUNDS PFIZER INC 2001-10-23 US disclosed
EP-1091943-A1 NON-PEPTIDYL INHIBITORS OF VLA-4 DEPENDENT CELL BINDING USEFUL IN TREATING INFLAMMATORY, AUTOIMMUNE, AND RESPIRATORY DISEASES Pfizer Products Inc. (US) 2001-04-18 EP disclosed
WO-2000000477-A1 NON-PEPTIDYL INHIBITORS OF VLA-4 DEPENDENT CELL BINDING USEFUL IN TREATING INFLAMMATORY, AUTOIMMUNE, AND RESPIRATORY DISEASES PFIZER PRODUCTS INC. (US) 2000-01-06 WO disclosed